Prospective Cohort Study of Children Diagnosed with Type 1 Diabetes in Türkiye Between 2018 to 2022

Turkish Pediatric Diabetes Working Group2,730 enrolled

Overview

Achieving glycemic targets with improved T1DM management reduces diabetes complications and the risk of progression. Thus, it is essential to identify the challenges in T1DM management within the country and develop strategies for improvement. In Türkiye, there is limited multicenter data regarding the clinical characteristics of children and adolescents with T1DM during the diagnosis and treatment process. This multicenter prospective cohort study aimed to determine the diagnostic and follow-up characteristics of children and adolescents with T1DM, assess the status of diabetes management in the country.

Study Type

OBSERVATIONAL

Enrollment

2,730

Conditions

Type 1 Diabetes Mellitus (T1DM)

Eligibility

Sex: ALLMin age: 2 MonthsMax age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Type 1 diabetes mellitus can develop in individuals between the ages of 2 months and 18 years. Exclusion Criteria: * other types of diabetes mellitus

Locations (1)

Ministry of Health Etlik City Hospital

Ankara, Yenimahalle, Turkey (Türkiye)

Outcomes

Primary Outcomes

HbA1c

Time frame: Through study completion, HbA1c will be measured during the 1st, 2nd, 3rd, 4th, and 5th years of treatment.

diabetes microvascular complications

Time frame: through study completion, diabetes microvascular complications will be assessed during the 1st, 2nd, 3rd, 4th, and 5th years of treatment.